Now a new study from Quebec published in the Journal of the American College of Cardiology provides new information about the rate of new-onset AF following TAVI.
The broad enthusiasm for TAVI (transcatheter aortic valve implantation) as it enters the marketplace has been partially offset by concerns about an increased risk of stroke associated with the procedure.
Ignacio Amat-Santos and colleagues followed 138 patients with no history of AF who underwent TAVI. 31.9% (44 patients) developed new-onset AF while in the hospital at a median time of 48 hours after the procedure.